Imatinib Cipla

Medicinal product

(Invented) name

Imatinib Cipla

Active substance (s)

Imatinibas

Strength

100 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA01, imatinib

Marketing authorisation holder

UAB Viasana, Lietuva

Date of authorisation

2020-03-27

Date of renewal

Documents

1245_001-002 Imatinib Cipla 2020-05-06.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

kapsulėje yra	1 vnt.
Imatinibas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103528	89630	1089630	lizdinė plokštelė	N120		Receptinis	LT/L/20/1245/001	Netiekiama	-	-	No	-	-	Download
104006	90111	1090111	lizdinė plokštelė	N60		Receptinis	LT/L/20/1245/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2020-03-27	Registruotas